Exelixis Inc (EXEL) President and CEO Michael Morrissey Sold $508,250 of Shares

Jan 18, 2020

President and CEO of Exelixis Inc (30-Year Financial, Insider Trades) Michael Morrissey (insider trades) sold 25,000 shares of EXEL on 01/16/2020 at an average price of $20.33 a share. The total sale was $508,250.

Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company. Exelixis Inc has a market cap of $6.02 billion; its shares were traded at around $19.82 with a P/E ratio of 10.15 and P/S ratio of 6.52. GuruFocus has detected 3 severe warning signs with Exelixis Inc. .

CEO Recent Trades:

President and CEO Michael Morrissey sold 25,000 shares of EXEL stock on 01/16/2020 at the average price of $20.33. The price of the stock has decreased by 2.51% since.
President and CEO Michael Morrissey sold 25,000 shares of EXEL stock on 01/08/2020 at the average price of $18.85. The price of the stock has increased by 5.15% since.
President and CEO Michael Morrissey sold 25,000 shares of EXEL stock on 01/02/2020 at the average price of $17.49. The price of the stock has increased by 13.32% since.

Directors and Officers Recent Trades:

Director Vincent T Marchesi sold 61,683 shares of EXEL stock on 01/15/2020 at the average price of $20.01. The price of the stock has decreased by 0.95% since.
Director George A Scangos sold 25,000 shares of EXEL stock on 01/15/2020 at the average price of $20.39. The price of the stock has decreased by 2.8% since.
Director Alan M Garber sold 86,956 shares of EXEL stock on 01/07/2020 at the average price of $18.01. The price of the stock has increased by 10.05% since.
Pres, Prod Dev & Med Aff & CMO Gisela Schwab sold 50,000 shares of EXEL stock on 01/07/2020 at the average price of $17.96. The price of the stock has increased by 10.36% since.
Director George A Scangos sold 25,000 shares of EXEL stock on 12/27/2019 at the average price of $18.25. The price of the stock has increased by 8.6% since.

For the complete insider trading history of EXEL, click here

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.